Health & Fitness
Wed, December 14, 2011
NEW YORK--([ BUSINESS WIRE ])--Harwood Feffer LLP ([ www.hfesq.com ]) is investigating potential claims against the board of directors of Synovis Life Technologies, Inc. (aSynovisa or the aCompanya) (NASDAQ: SYNO) concerning the proposed acquisition of the Company by Baxter International, Inc. (aBaxtera) in a transaction valued at approximately $325 million.
On December 13, 2011, Synovis announced that it had entered into a definitive merger agreement pursuant to which the Company will be acquired by Baxter. Under the terms of the agreement, Synovis shareholders will receive $28.00 per share in cash.
Our investigation concerns whether the board of directors is fulfilling its fiduciary duties, maximizing the value of Synovis and obtaining full and fair consideration for Synovis stockholders.
If you own Synovis shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
| Robert I. Harwood, Esq. | ||
| Benjamin Sachs-Michaels | ||
Harwood Feffer LLP | ||
| 488 Madison Avenue | ||
New York, New York 10022 | ||
| Phone Numbers: | (877) 935-7400 | |
| (212)935-7400 | ||
Email: [ bsachsmichaels@hfesq.com ] | ||
Website: [ http://www.hfesq.com ] | ||
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ([ http://www.hfesq.com ]) for more information about the firm.
Attorney Advertising. 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ([ www.hfesq.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
